Septic Failure After One-Stage Exchange for Prosthetic Joint Infection of the Hip: Microbiological Implications

Iman Godarzi Bakhtiari1, Georges Vles2, Sophia-Marlene Busch1

  • 1Department of Orhopaedic Surgery, ENDO-Klinik Hamburg, Hamburg, Germany.

Abstract

Insights

Septic failure after hip prosthetic joint infection (PJI) treatment often involves new bacteria, necessitating repeat cultures for effective treatment. Microbiological challenges in these cases require further investigation and extended patient follow-up.

Area of Science:

  • Orthopedics
  • Infectious Diseases
  • Microbiology

Background:

  • Prosthetic joint infection (PJI) management, particularly after 1-stage exchange for hip PJI, has unclear microbiological implications regarding septic failure.
  • Understanding the microbial landscape post-treatment is crucial for optimizing patient outcomes.

Purpose of the Study:

  • To investigate the microbiological characteristics and antibiotic resistance patterns in patients experiencing septic failure after 1-stage exchange for hip PJI.
  • To determine if septic failure presents unique microbiological challenges compared to initial infections.

Main Methods:

  • Retrospective analysis of 77 patients who underwent 1-stage exchange for hip PJI between 2001-2017.
  • Collection and analysis of preoperative and postoperative microbiological data, including pathogen identification and antibiotic susceptibility.
  • Evaluation of comorbidities, previous procedures, and time to septic failure.

Main Results:

  • In 55% of cases, septic failure was associated with a shift to different causative microorganisms compared to the initial infection.
  • A significant decrease in the incidence of polymicrobial infections and infections caused by highly virulent microorganisms was observed.
  • While changes in specific resistant strains (e.g., rifampicin-resistant staphylococci) and gram-negative pathogens were noted, they did not reach statistical significance.

Conclusions:

  • The frequent emergence of different bacterial species in recurrent hip PJI underscores the importance of repeat microbiological analysis for guiding treatment decisions.
  • Current data do not conclusively demonstrate increased microbiological complexity in septic failure after 1-stage exchange.
  • Extended follow-up periods are recommended for patients with hip PJI to better understand long-term outcomes and potential microbiological shifts.

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
44
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
125
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
63
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.8K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
73
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
147